- 関
- MAP kinase kinase 2
PrepTutorEJDIC
- Maine / Middle English / Middle East
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/08/04 11:57:16」(JST)
[Wiki en表示]
Main article: Mitogen-activated protein kinase kinase
Mitogen-activated protein kinase kinase 2 |
PDB rendering based on 1s9i. |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
"lastQuery":"Chain Type: there is a Protein chain but not any DNA or RNA or Hybrid\nand\nTAXONOMY is Viruses\nand\nTAXONOMY is only Bacteria (eubacteria) with Viruses\n","hetId":null,"resultCount":4316,"structureId":null,"queryCount":3,"queryId":"E9B94ECE" {"lastQuery":"Chain Type: there is a Protein chain but not any DNA or RNA or Hybrid\nand\nTAXONOMY is Viruses\nand\nTAXONOMY is only Bacteria (eubacteria) with Viruses\n","hetId":null,"resultCount":4316,"structureId":null,"queryCount":3,"queryId":"E9B94ECE"}
|
|
|
Identifiers |
Symbols |
MAP2K2 ; MAPKK2; MEK2; MKK2; PRKMK2 |
External IDs |
OMIM: 601263 MGI: 1346867 HomoloGene: 48591 ChEMBL: 2964 GeneCards: MAP2K2 Gene |
EC number |
2.7.12.2 |
Gene ontology |
Molecular function |
• nucleotide binding
• protein serine/threonine kinase activity
• protein serine/threonine kinase activity
• protein serine/threonine/tyrosine kinase activity
• protein tyrosine kinase activity
• protein binding
• ATP binding
• protein complex scaffold
|
Cellular component |
• extracellular region
• soluble fraction
• nucleus
• mitochondrion
• early endosome
• late endosome
• Golgi apparatus
• cytosol
• focal adhesion
• cell cortex
|
Biological process |
• MAPK cascade
• activation of MAPKK activity
• activation of MAPK activity
• toll-like receptor signaling pathway
• MyD88-dependent toll-like receptor signaling pathway
• MyD88-independent toll-like receptor signaling pathway
• protein phosphorylation
• epidermal growth factor receptor signaling pathway
• small GTPase mediated signal transduction
• Ras protein signal transduction
• axon guidance
• Toll signaling pathway
• insulin receptor signaling pathway
• fibroblast growth factor receptor signaling pathway
• regulation of stress-activated MAPK cascade
• toll-like receptor 1 signaling pathway
• toll-like receptor 2 signaling pathway
• toll-like receptor 3 signaling pathway
• toll-like receptor 4 signaling pathway
• TRIF-dependent toll-like receptor signaling pathway
• innate immune response
• nerve growth factor receptor signaling pathway
• stress-activated MAPK cascade
• ERK1 and ERK2 cascade
• regulation of Golgi inheritance
• positive regulation of cell motility
• regulation of early endosome to late endosome transport
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
5605 |
26396 |
|
Ensembl |
ENSG00000126934 |
ENSMUSG00000035027 |
|
UniProt |
P36507 |
Q63932 |
|
RefSeq (mRNA) |
NM_030662.3 |
NM_023138.4 |
|
RefSeq (protein) |
NP_109587.1 |
NP_075627.2 |
|
Location (UCSC) |
Chr 19:
4.09 – 4.12 Mb |
Chr 10:
80.57 – 80.59 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Dual specificity mitogen-activated protein kinase kinase 2 is an enzyme that in humans is encoded by the MAP2K2 gene.[1]
Contents
- 1 Function
- 2 Interactions
- 3 References
- 4 Further reading
- 5 External links
Function
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3.
The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases.
The inhibition or degradation of this kinase is found to be involved in the pathogenesis of Yersinia and anthrax.[2]
Interactions
MAP2K2 has been shown to interact with MAPK3[3][4][5] and ARAF.[6]
References
- ^ Zheng CF, Guan KL (Jun 1993). "Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2". J Biol Chem 268 (15): 11435–9. PMID 8388392.
- ^ "Entrez Gene: MAP2K2 mitogen-activated protein kinase kinase 2".
- ^ Marti, A; Luo Z; Cunningham C; Ohta Y; Hartwig J; Stossel T P; Kyriakis J M; Avruch J (Jan 1997). "Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-alpha activation of SAPK in melanoma cells". J. Biol. Chem. (UNITED STATES) 272 (5): 2620–8. doi:10.1074/jbc.272.5.2620. ISSN 0021-9258. PMID 9006895.
- ^ Butch, E R; Guan K L (Feb 1996). "Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2". J. Biol. Chem. (UNITED STATES) 271 (8): 4230–5. doi:10.1074/jbc.271.8.4230. ISSN 0021-9258. PMID 8626767.
- ^ Zheng, C F; Guan K L (Nov 1993). "Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases". J. Biol. Chem. (UNITED STATES) 268 (32): 23933–9. ISSN 0021-9258. PMID 8226933.
- ^ Yin, Xiang L; Chen She; Yan Jun; Hu Yun; Gu Jian X (Feb 2002). "Identification of interaction between MEK2 and A-Raf-1". Biochim. Biophys. Acta (Netherlands) 1589 (1): 71–6. doi:10.1016/S0167-4889(01)00188-4. ISSN 0006-3002. PMID 11909642.
Further reading
- Joseph AM, Kumar M, Mitra D (2005). "Nef: "necessary and enforcing factor" in HIV infection.". Curr. HIV Res. 3 (1): 87–94. doi:10.2174/1570162052773013. PMID 15638726.
- Stove V, Verhasselt B (2006). "Modelling thymic HIV-1 Nef effects.". Curr. HIV Res. 4 (1): 57–64. doi:10.2174/157016206775197583. PMID 16454711.
- Charest DL, Mordret G, Harder KW, et al. (1993). "Molecular cloning, expression, and characterization of the human mitogen-activated protein kinase p44erk1". Mol. Cell. Biol. 13 (8): 4679–90. PMC 360094. PMID 7687743.
- Dérijard B, Raingeaud J, Barrett T, et al. (1995). "Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms". Science 267 (5198): 682–5. doi:10.1126/science.7839144. PMID 7839144.
- Alessi DR, Saito Y, Campbell DG, et al. (1994). "Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1". EMBO J. 13 (7): 1610–9. PMC 394991. PMID 8157000.
- Zheng CF, Guan KL (1993). "Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases". J. Biol. Chem. 268 (32): 23933–9. PMID 8226933.
- Wu J, Harrison JK, Dent P, et al. (1993). "Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2". Mol. Cell. Biol. 13 (8): 4539–48. PMC 360070. PMID 8393135.
- Moriguchi T, Gotoh Y, Nishida E (1996). "Activation of two isoforms of mitogen-activated protein kinase kinase in response to epidermal growth factor and nerve growth factor". Eur. J. Biochem. 234 (1): 32–8. doi:10.1111/j.1432-1033.1995.032_c.x. PMID 8529659.
- Butch ER, Guan KL (1996). "Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2". J. Biol. Chem. 271 (8): 4230–5. doi:10.1074/jbc.271.8.4230. PMID 8626767.
- Papin C, Denouel A, Calothy G, Eychène A (1996). "Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system". Oncogene 12 (10): 2213–21. PMID 8668348.
- Downey GP, Butler JR, Brumell J, et al. (1996). "Chemotactic peptide-induced activation of MEK-2, the predominant isoform in human neutrophils. Inhibition by wortmannin". J. Biol. Chem. 271 (35): 21005–1011. doi:10.1074/jbc.271.35.21005. PMID 8702863.
- Khoo S, Cobb MH (1997). "Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion". Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5599–604. doi:10.1073/pnas.94.11.5599. PMC 20824. PMID 9159118.
- Li CJ, Ueda Y, Shi B, et al. (1997). "Tat protein induces self-perpetuating permissivity for productive HIV-1 infection". Proc. Natl. Acad. Sci. U.S.A. 94 (15): 8116–20. doi:10.1073/pnas.94.15.8116. PMC 21566. PMID 9223324.
- Menegon A, Leoni C, Benfenati F, Valtorta F (1997). "Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum". Biochem. Biophys. Res. Commun. 238 (3): 800–5. doi:10.1006/bbrc.1997.7393. PMID 9325171.
- Denouel-Galy A, Douville EM, Warne PH, et al. (1998). "Murine Ksr interacts with MEK and inhibits Ras-induced transformation". Curr. Biol. 8 (1): 46–55. doi:10.1016/S0960-9822(98)70019-3. PMID 9427625.
- Gibellini D, Bassini A, Pierpaoli S, et al. (1998). "Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells". J. Immunol. 160 (8): 3891–8. PMID 9558095.
- Duesbery NS, Webb CP, Leppla SH, et al. (1998). "Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor". Science 280 (5364): 734–7. doi:10.1126/science.280.5364.734. PMID 9563949.
- Ganju RK, Munshi N, Nair BC, et al. (1998). "Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi's Sarcoma Cells". J. Virol. 72 (7): 6131–7. PMC 110419. PMID 9621077.
- Tanimura S, Chatani Y, Hoshino R, et al. (1998). "Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering". Oncogene 17 (1): 57–65. doi:10.1038/sj.onc.1201905. PMID 9671314.
External links
- GeneReviews/NCBI/NIH/UW entry on Cardiofaciocutaneous Syndrome
PDB gallery
|
|
|
1s9i: X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP
|
|
|
|
Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12)
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20)
|
|
|
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
|
|
Polo kinase (EC 2.7.11.21) |
|
|
Cyclin-dependent kinase (EC 2.7.11.22) |
- CDK1
- CDK2
- CDKL2
- CDK3
- CDK4
- CDK5
- CDKL5
- CDK6
- CDK7
- CDK8
- CDK9
- CDK10
- CDC2L5
- CRKRS
- PCTK1
- PCTK2
- PCTK3
- PFTK1
- CDC2L1
|
|
(RNA-polymerase)-subunit kinase (EC 2.7.11.23) |
- RPS6KA5
- RPS6KA4
- P70S6 kinase
- P70-S6 Kinase 1
- RPS6KB2
- RPS6KA2
- RPS6KA3
- RPS6KA1
- RPS6KC1
|
|
Mitogen-activated protein kinase (EC 2.7.11.24) |
- Extracellular signal-regulated
- MAPK1
- MAPK3
- MAPK4
- MAPK6
- MAPK7
- MAPK12
- MAPK15
- C-Jun N-terminal
- P38 mitogen-activated protein
|
|
MAP3K (EC 2.7.11.25) |
- MAP kinase kinase kinases
- MAP3K1
- MAP3K2
- MAP3K3
- MAP3K4
- MAP3K5
- MAP3K6
- MAP3K7
- MAP3K8
- RAFs
- MLKs
- MAP3K12
- MAP3K13
- MAP3K9
- MAP3K10
- MAP3K11
- MAP3K7
- ZAK
- CDC7
- MAP3K14
|
|
Tau-protein kinase (EC 2.7.11.26) |
|
|
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27) |
-
|
|
Tropomyosin kinase (EC 2.7.11.28) |
-
|
|
Low-density-lipoprotein receptor kinase (EC 2.7.11.29) |
-
|
|
Receptor protein serine/threonine kinase (EC 2.7.11.30) |
- Bone morphogenetic protein receptors
- BMPR1
- BMPR1A
- BMPR1B
- BMPR2
- ACVR1
- ACVR1B
- ACVR1C
- ACVR2A
- ACVR2B
- ACVRL1
- Anti-Müllerian hormone receptor
|
|
|
|
Dual-specificity kinases (EC 2.7.12)
|
|
MAP2K |
- MAP2K1
- MAP2K2
- MAP2K3
- MAP2K4
- MAP2K5
- MAP2K6
- MAP2K7
|
|
|
|
- B
- enzm
- 1.1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 10
- 11
- 13
- 14
- 15-18
- 2.1
- 3.1
- 4.1
- 5.1
- 6.1-3
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Xanthomonas euvesicatoria type III effector XopQ interacts with tomato and pepper 14-3-3 isoforms to suppress effector-triggered immunity.
- Teper D, Salomon D, Sunitha S, Kim JG, Mudgett MB, Sessa G.SourceDepartment of Molecular Biology and Ecology of Plants, Tel Aviv University, 69978, Tel Aviv, Israel.
- The Plant journal : for cell and molecular biology.Plant J.2013 Nov 26. doi: 10.1111/tpj.12391. [Epub ahead of print]
- Effector-triggered immunity (ETI) to host-adapted pathogens is associated with elicitation of cell death at the infection site. The plant-pathogenic bacterium Xanthomonas euvesicatoria (Xcv) interferes with plant cellular processes by injecting effector proteins into host cells through the type III
- PMID 24279912
- Rapamycin Induces Mitogen-activated Protein (MAP) Kinase Phosphatase-1 (MKP-1) Expression through Activation of Protein Kinase B and Mitogen-activated Protein Kinase Kinase Pathways.
- Rastogi R, Jiang Z, Ahmad N, Rosati R, Liu Y, Beuret L, Monks R, Charron J, Birnbaum MJ, Samavati L.SourceFrom the Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine and Detroit Medical Center, Detroit, Michigan 48201.
- The Journal of biological chemistry.J Biol Chem.2013 Nov 22;288(47):33966-77. doi: 10.1074/jbc.M113.492702. Epub 2013 Oct 14.
- Mitogen-activated protein kinase phosphatase-1 (MKP-1), also known as dual specificity phosphatase-1 (DUSP-1), plays a crucial role in the deactivation of MAPKs. Several drugs with immune-suppressive properties modulate MKP-1 expression as part of their mechanism of action. We investigated the effec
- PMID 24126911
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition.
- Wagle N, Van Allen EM, Treacy DJ, Frederick DT, Cooper ZA, Taylor-Weiner A, Rosenberg M, Goetz EM, Sullivan RJ, Farlow DN, Friedrich DC, Anderka K, Perrin D, Johannessen CM, McKenna A, Cibulskis K, Kryukov G, Hodis E, Lawrence DP, Fisher S, Getz G, Gabriel SB, Carter SL, Flaherty KT, Wargo JA, Garraway LA.Source1Department of Medical Oncology, Dana-Farber Cancer Institute; 2Department of Medicine, Brigham and Women's Hospital; 3Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; 4Broad Institute of Harvard and MIT; and 5Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts.
- Cancer discovery.Cancer Discov.2013 Nov 21. [Epub ahead of print]
- Treatment of BRAF-mutant melanoma with combined dabrafenib and trametinib, which target RAF and the downstream MAP-ERK kinase (MEK)1 and MEK2 kinases, respectively, improves progression-free survival and response rates compared with dabrafenib monotherapy. Mechanisms of clinical resistance to combin
- PMID 24265154
Japanese Journal
- MEK1 and MEK2, different regulators of the G_1/S transition
- Mek2 is dispensable for mouse growth and development
Related Links
- 米国CST社の日本法人CSTジャパン株式会社【公式サイト】MEK2 Antibodyページ。高品質の研究用試薬、米国本社の開発研究者による技術的サポートをご提供しております。
- MEK-2(MEK2) マイクエクステンションキット メールアドレス ※バックナンバーメールマガジンが正しく届かなくなったら、こちらのページから詳細を報告してください YouTubeCQオームチャンネル 動画一覧や最新動画のチェックはこちらを ...
Related Pictures
★リンクテーブル★
[★]
層
|
増殖因子
|
細胞膜
|
Grb2 Sos Ras
|
細胞質
|
|
MAPKKKK
|
PAK3
|
MAPKKK
|
Raf-1/A-Raf
|
MAPKK
|
B-Raf/Mos
|
MAPK
|
MEK1/MEK2
|
基質
|
ERK1/ERK2, p90rsk, MNK1/MNK2, Sos, cPLA2, EGFR, Elk-1, Ets1, Sap1a, STAT, Map2, Tau
|
[★]
- 英
- MAP kinase kinase 2、MEK2
- 関
- マイトジェン活性化プロテインキナーゼキナーゼ2
[★]
- 関
- MEK2、mitogen-activated protein kinase kinase 2
[★]
- 関
- medical electronics、medical engineering